Gender Differences Relating to Metabolic Syndrome and Proinflammation in Finnish Subjects with Elevated Blood Pressure
Table 1
Demographic, clinical, biochemical, and lifestyle factors of subjects.
Variables
Men
Women
-value
()
Demographic
Age, years
47 (6)
48 (6)
0.38
Age distribution, years
36–57
36–57
NS
Body mass index, kg/
27.1 (3.8)
27.1 (5.2)
.98
Waist circumference, cm
95 (11)
85 (13)
.001
Clinical
Blood pressure, mmHg
Systolic
146 (15)
144 (14)
.10
Diastolic
88 (9)
85 (8)
.001
Medication for hypertension (%)
40 (14)
40 (15)
.93
Medication for hyperlipidemia (%)
12 (4.4)
5 (2.0)
.092
Medication for diabetes (%)
6 (2.0)
7 (3.0)
.75
Biochemical
Total cholesterol, mmol/l
5.9 (1.1)
5.7 (1.0)
.11
HDL cholesterol, mmol/l
1.3 (0.3)
1.5 (0.4)
.001
Triglycerides, mmol/l
1.7 (1.4)
1.3 (0.6)
.001
fP-glucose, mmol/l
6.0 (0.7)
5.7 (0.6)
.001
Lifestyle
Number of current smokers (%)
94 (34)
52 (19)
.001
Number of alcohol users (%)
243 (88)
212 (78)
.001
Number of physically active (%)
87 (31)
78 (27)
.48
HDL: high density lipoprotein; fP: fasting plasma. (mean SD in parentheses for continuous variables number of subjects, percentage in parentheses for dichotomous variables).
